Skip to main content
. 2015 Aug 20;11(11):2705–2715. doi: 10.1080/21645515.2015.1019186

Table 1.

Effects of CHMI on activities of individual subjects in the DNA/Ad and AdCA trials

  ELISpot CD8+ T cell IFN-γ CD8+ T cell IFN-γ EM Antibody
Vaccine Status Vol. CSP AMA1 CSP AMA1 CSP AMA1 CSP AMA1
DNA-Ad P v06 0 +1.2 0 0 0 0 −1.8 −1.3
  v10 0 −2.01 0 −4.2 0 −11.51 −2.3 −1.4
  v11 −3.21 −2.61 −9.91 −4.51 −28.91 −5.21 −4.0 −4.4
  v18 −1.61 −1.81 −2.41 −2.51 −2.41 −3.01 −1.4 −2.1
  Non-P v01 +4.9* +1.8 0 +1.4 0 0 −1.7 +1.1
  v02 0 +3.0 0 0 0 0 −1.2 +2.3
  v03 +1.6 +2.5 −3.5 −2.5 0 0 −2.2 +1.6
  v05 0 +3.3 1.0* +1.1 0 0 +2.7 +2.5
  v09 0 +4.8* +2.2* 1.0 0 0 +1.4 +2.0
  v12 +1.8 +1.2 +1.1* 1.0 0 0 1.0 −2.8
  v13 0 +1.4 0 0 0 0 1.0 +4.2
  v15 0 +2.8 −4.4 −1.2 0 0 1.0 +1.1
  v16 0 +4.7 0 −3.3 0 0 1.0 +3.0
  v17 +1.1* +2.0 +1.45* −4.0 0 0 +6.7 +3.7
  v19 0 +5.7* −2.2 −4.2 0 0 −3.6 1.0
Ad-CA Non-P v118 −2.1 −1.4 NT NT NT NT +4.6 +133.3
  v119 −2.1 −3.8 −1.1 −1.7 −1.2 −1.7 +3.9 +2.0
  v125 −1.7 −1.6 1.0 −2.1 0 −1.9 −1.5 +7.1
  v126 −2.4 −1.4 −8.5 −2.2 0 −1.5 +8.5 +74.5
  v127 −1.9 −2.4 −1.2 −3.2 −1.2 −3.2 −1.7 +7.3
  v128 −4.1 −1.9 +1.4 +1.3 NT +1.4 −1.7 +10.0
  v147 −1.3 −1.2 −2.7 +1.3 −2.1 0 1.0 +146.0
  v149 −1.1 −1.2 NT NT NT NT +5.8 +9.7
  v156 −2.5 −2.1 −1.2 −2.4 −1.6 −1.0 +1.5 +9.2
  v160 −1.5 −1.3 −3.6 −3.2 −6.5 −23.8 +1.8 +2.1
  v172 −2.0 −1.6 −1.1 −2.7 0 −24.9 +1.1 +7.7
  v173 1.0 −1.3 0 −1.2 0 0 0 +15.3
  v179 −2.4 −1.1 −2.1 −1.9 0 −1.4 −1.4 +28.2
  v184 −4.9 −3.1 −1.7 −1.1 0 0 0 +475.0
  v194 −3.5 −1.9 0 −1.2 0 0 −2.4 +5.1
  v195 0 −4.2 1.0* −1.5 0 −1.2* −1.4 +10.1
  v196 −2.9 −1.8 −1.2 −2.6 0 −2.4 +2.0 +16.2

The effects of CHMI on pre-CHMI cellular and antibody activities are shown for each volunteer in the DNA/Ad and AdCA trials. The fold-change of pre- and post-CHMI activities is shown as a rise (+) or fall (−). The threshold for significance was fold-changes >±1.5, which was the range of changes in non-immunized infectivity controls: rises are shown in blue boxes, and falls are shown in green boxes.

1

Fold-changes of responses to immunodominant peptide pools.

*

Activity was negative pre-CHMI but was positive post-CHMI. 0: Pre-CHMI and post-CHMI activities were negative.